Barbara Burtness

Yale Cancer Center — United States

Medicine · Health Sciences

74h-index38.1kcitations732works8.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(350), Lung Cancer Treatments and Mutations(204), Cancer Immunotherapy and Biomarkers(119), Cancer Diagnosis and Treatment(76), Radiomics and Machine Learning in Medical Imaging(74)

Publications726 total

JADE: phase 3 study of sequential dostarlimab post chemoradiotherapy in patients with locally advanced unresected HNSCC
Future Oncology·2026Open Access
NN-01-195, a Novel Conjugate of HSP90 and AURKA Inhibitors, Effectively Targets Solid Tumors
Molecular Cancer Therapeutics·2026Open Access
STING predicts patterns of failure in locally advanced head and neck squamous cell carcinoma
JNCI Cancer Spectrum·2026Open Access
Automated Lymph Node and Extranodal Extension Assessment Improves Risk Stratification in Oropharyngeal Carcinoma
Journal of Clinical Oncology·2025· 1 citedOpen Access
Re-defining standards of care in resectable head and neck squamous cell carcinoma—lessons from KEYNOTE-689 and NIVOPOSTOP
The Oncologist·2025Open Access
In vivo assessment of differential toxicity of cancer treatment drugs in Fanconi’s Anemia
2025Open Access
Functional Impact of Transoral Surgery and Risk-Based Adjuvant Therapy in Human Papillomavirus–Associated Oropharyngeal Cancer: Swallowing Outcomes From ECOG-ACRIN E3311
JCO oncology advances.·2025Open Access
Abstract A029: Mechanistic insight into a germline <i>KDM3C</i> polymorphism associated with chemoradiotherapy outcomes in cancer
Molecular Cancer Therapeutics·2025
HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors
Future Oncology·2025· 2 citedOpen Access
Health-related quality of life outcomes from KEYNOTE-412: chemoradiotherapy with or without pembrolizumab in participants with head and neck squamous cell carcinoma
Frontiers in Oncology·2025Open Access
Xevinapant or Placebo Plus Platinum-Based Chemoradiotherapy in Unresected Locally Advanced Squamous Cell Carcinoma of the Head and Neck (TrilynX): A Randomized, Phase III Study
Journal of Clinical Oncology·2025· 7 citedOpen Access
Evaluation of a Novel Prognostic System for Surgically Resected Oral Cavity Carcinoma
Head & Neck·2025
Supplementary Materials1 from Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163
2025Open Access
Data from Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163
2025Open Access
Supplementary Table1 from Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163
2025Open Access
Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus–Initiated Oropharynx Cancer
Journal of Clinical Oncology·2025· 7 cited
AURKA inhibition amplifies DNA replication stress to foster WEE1 kinase dependency and synergistic antitumor effects with WEE1 inhibition in cancers
2025Open Access
Long-term results of the randomized, phase 3 KEYNOTE-412 trial of pembrolizumab (pembro) or placebo (pbo) plus concurrent chemoradiotherapy (CRT) for unresected, locally advanced head and neck squamous cell carcinoma (LA HNSCC).
Journal of Clinical Oncology·2025· 7 cited
Phase 2 trial of dual EGFR inhibition with cetuximab and afatinib in patients with recurrent/metastatic head and neck squamous cell cancers (HNSCC).
Journal of Clinical Oncology·2025· 2 cited
FDG-PET Intensity Normalization Improves Radiomics-Based Survival Prediction in Patients with Oropharyngeal Cancer: A Comparison of the Standardized Uptake Value with Alternative Normalization Techniques
American Journal of Neuroradiology·2025· 1 citedOpen Access
page 1 of 37Next →

Frequent Co-authors

Kevin J. Harrington(9), Maura L. Gillison(9), John A. Ridge(9), Robert I. Haddad(9), Jill Gilbert(9), Makoto Tahara(8), Lisa Licitra(8), Ranee Mehra(8), A. Dimitrios Colevas(8), Richard Greil(7), Denis Soulières(7), Gilberto de Castro(7), Jonathan D. Cheng(7), Danny Rischin(7), David G. Pfister(7), David M. Brizel(7), Anthony J. Cmelak(7), Harlan A. Pinto(7), Amanda Psyrri(6), Thorsten Fuereder(6)